The a2 Milk company (ASX:A2M) has announced its Chief Scientific Officer will step down and take on a new role as Chief Scientific Advisor to the CEO for the next three years.
The company also plans to establish two new roles in clinical and commercial science.
a2 Milk Company recently announced it’s expanding into South Korea under a sales and distribution deal with local pharmaceutical giant Yuhan.
The company sells dairy products which contain only the A2 protein and not A1 protein.
Shares in A2 Milk (ASX:A2M) are trading 2.12 per cent higher to $12.04